Selected research
Industry Research
Injections for SMA Industry Research Report 2026
Market perspective
The global Injections for SMA market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Injections for SMA is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Injections for SMA is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Injections for SMA include Novartis, Biogen and Ionis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Injections for SMA market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Injections for SMA Market by Company
Novartis
Biogen
Ionis Pharmaceuticals
Injections for SMA Segment by Type
Antisense Oligonucleotides
Gene Therapy
Injections for SMA Segment by Application
Hospital
Clinic
Other
Injections for SMA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injections for SMA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injections for SMA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injections for SMA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Injections for SMA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Injections for SMA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Injections for SMA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antisense Oligonucleotides
- Gene Therapy
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis
- Biogen
- Ionis Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Injections for SMA Market Size (2021-2032)
- 2.2.2 Global Injections for SMA Sales (2021-2032)
- 2.2.3 Global Injections for SMA Market Average Price (2021-2032)
- 2.3 Injections for SMA by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antisense Oligonucleotides
- 2.3.3 Gene Therapy
- 2.4 Injections for SMA by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Injections for SMA Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Injections for SMA Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Injections for SMA Revenue of Manufacturers (2021-2026)
- 3.4 Global Injections for SMA Average Price by Manufacturers (2021-2026)
- 3.5 Global Injections for SMA Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Injections for SMA, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Injections for SMA, Product Type & Application
- 3.8 Global Manufacturers of Injections for SMA, Established Date
- 3.9 Global Injections for SMA Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Injections for SMA Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Biogen
- 4.2.1 Biogen Company Information
- 4.2.2 Biogen Business Overview
- 4.2.3 Biogen Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biogen Injections for SMA Product Portfolio
- 4.2.5 Biogen Recent Developments
- 4.3 Ionis Pharmaceuticals
- 4.3.1 Ionis Pharmaceuticals Company Information
- 4.3.2 Ionis Pharmaceuticals Business Overview
- 4.3.3 Ionis Pharmaceuticals Injections for SMA Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ionis Pharmaceuticals Injections for SMA Product Portfolio
- 4.3.5 Ionis Pharmaceuticals Recent Developments
5 Global Injections for SMA Market Scenario by Region
- 5.1 Global Injections for SMA Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Injections for SMA Sales by Region: 2021-2032
- 5.2.1 Global Injections for SMA Sales by Region: 2021-2026
- 5.2.2 Global Injections for SMA Sales by Region: 2027-2032
- 5.3 Global Injections for SMA Revenue by Region: 2021-2032
- 5.3.1 Global Injections for SMA Revenue by Region: 2021-2026
- 5.3.2 Global Injections for SMA Revenue by Region: 2027-2032
- 5.4 North America Injections for SMA Market Facts & Figures by Country
- 5.4.1 North America Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Injections for SMA Sales by Country (2021-2032)
- 5.4.3 North America Injections for SMA Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Injections for SMA Market Facts & Figures by Country
- 5.5.1 Europe Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Injections for SMA Sales by Country (2021-2032)
- 5.5.3 Europe Injections for SMA Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Injections for SMA Market Facts & Figures by Country
- 5.6.1 Asia Pacific Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Injections for SMA Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Injections for SMA Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Injections for SMA Market Facts & Figures by Country
- 5.7.1 South America Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Injections for SMA Sales by Country (2021-2032)
- 5.7.3 South America Injections for SMA Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Injections for SMA Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Injections for SMA Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Injections for SMA Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Injections for SMA Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Injections for SMA Sales by Type (2021-2032)
- 6.1.1 Global Injections for SMA Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Injections for SMA Sales Market Share by Type (2021-2032)
- 6.2 Global Injections for SMA Revenue by Type (2021-2032)
- 6.2.1 Global Injections for SMA Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Injections for SMA Revenue Market Share by Type (2021-2032)
- 6.3 Global Injections for SMA Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Injections for SMA Sales by Application (2021-2032)
- 7.1.1 Global Injections for SMA Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Injections for SMA Sales Market Share by Application (2021-2032)
- 7.2 Global Injections for SMA Revenue by Application (2021-2032)
- 7.2.1 Global Injections for SMA Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Injections for SMA Revenue Market Share by Application (2021-2032)
- 7.3 Global Injections for SMA Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Injections for SMA Value Chain Analysis
- 8.1.1 Injections for SMA Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Injections for SMA Production Mode & Process
- 8.2 Injections for SMA Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Injections for SMA Distributors
- 8.2.3 Injections for SMA Customers
9 Global Injections for SMA Analyzing Market Dynamics
- 9.1 Injections for SMA Industry Trends
- 9.2 Injections for SMA Industry Drivers
- 9.3 Injections for SMA Industry Opportunities and Challenges
- 9.4 Injections for SMA Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst